n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide has been researched along with n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide in 2 studies
Studies (n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide) | Trials (n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide) | Recent Studies (post-2010) (n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide) | Studies (n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide) | Trials (n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide) | Recent Studies (post-2010) (n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide) |
---|---|---|---|---|---|
18 | 5 | 13 | 149 | 13 | 63 |
Protein | Taxonomy | n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide (IC50) | n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide (IC50) |
---|---|---|---|
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.007 | |
Carbonic anhydrase 1 | Homo sapiens (human) | 0.031 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 0.011 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.007 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.007 | |
Carbonic anhydrase 4 | Bos taurus (cattle) | 0.065 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, A; Kamiyama, H; Kotake, Y; Mabuchi, M; Minoshima, Y; Mitsuhashi, KO; Owa, T; Sagane, K; Sugi, NH; Takahashi, K; Tanaka, A; Uehara, T; Uesugi, M; Yamamoto, N; Yokoi, A; Yoshida, T | 1 |
Cai, Q; Donovan, KA; Eleuteri, NA; Faust, TB; Fischer, ES; Gray, NS; Li, Z; Nowak, RP; Yoon, H; Zhang, T | 1 |
2 other study(ies) available for n-(3-cyano-4-methyl-1h-indol-7-yl)-3-cyanobenzene-sulfonamide and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Article | Year |
---|---|
Selective degradation of splicing factor CAPERĪ± by anticancer sulfonamides.
Topics: Antineoplastic Agents; Gene Knockdown Techniques; Humans; Indoles; Nuclear Proteins; Proteolysis; RNA Splicing; RNA-Binding Proteins; Sulfonamides | 2017 |
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
Topics: Amino Acid Motifs; Animals; Benzamides; Cryoelectron Microscopy; Fluorescence Resonance Energy Transfer; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Kinetics; Protein Binding; Protein Domains; Protein Interaction Mapping; Protein Structure, Secondary; Proteolysis; RNA Recognition Motif Proteins; RNA-Binding Proteins; Spodoptera; Sulfonamides; Ubiquitin-Protein Ligases; Xenopus | 2020 |